文献速递焦虑、强迫与应激相关障碍会诊联络精神医学

网络与面对面认知行为疗法治疗健康焦虑的随机非劣效性试验

Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety: A Randomized Noninferiority Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2020-01-01

这项随机非劣效性临床试验纳入204例健康焦虑患者,比较12周网络版与面对面个体认知行为疗法(CBT)的效果。结果显示网络版CBT在改善健康焦虑症状上非劣于面对面CBT,且治疗师每周投入时间及净社会成本更低,不良事件无显著组间差异。

要点

  • 网络版CBT在改善健康焦虑症状上非劣于面对面CBT(ITT分析B=0.00,95%CI上限1.98)。
  • 治疗师每周每患者投入时间网络版10.0分钟,面对面45.6分钟。
  • 网络版净社会成本更低(治疗期点差异3854美元),不良事件无显著组间差异。

核心结论

  • 网络版CBT治疗健康焦虑非劣于面对面CBT,且净社会成本更低。
  • 网络版CBT有潜力增加循证治疗的可及性。

研究设计与样本

  • 随机非劣效性临床试验,基于初级保健诊所,纳入健康焦虑主要诊断患者。
  • 共204例患者按1:1随机分配至12周网络版CBT(102例)或面对面个体CBT(102例)。
  • 分析从意向性治疗和符合方案集(仅完成者)两个角度进行,主要结局为基线至第12周健康焦虑症状变化。

主要发现

  • 网络版CBT与面对面CBT的症状变化差异的单侧95%CI上限在ITT分析(B=0.00,上限1.98;Cohen d=0.00,上限0.23)和符合方案集分析(B=0.01,上限2.17;Cohen d=0.00,上限0.25)中均落在非劣效界值内。
  • 组间效应未受初始症状水平、招募途径或患者治疗偏好调节。
  • 治疗师每周每患者投入时间网络版10.0分钟,面对面45.6分钟;网络版净社会成本更低(治疗期点差异3854美元)。
  • 不良事件数量无显著组间差异,未报告严重不良事件。

关键数值与推荐

  • 非劣效界值为健康焦虑量表(HAI,理论范围0-54分)2.25分。
  • 非劣效性在ITT和符合方案集分析中均成立。

临床怎么用

  • 网络版CBT可作为健康焦虑的循证治疗选择,尤其适合资源有限或面对面治疗可及性差的情况。
  • 网络版CBT可降低治疗师时间投入和净社会成本,同时保持与面对面CBT相当的疗效。

局限性

  • 原文未报告具体的局限性描述。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Health anxiety is a common and often chronic mental health problem associated with distress, substantial costs, and frequent attendance throughout the health care system. Face-to-face cognitive behavior therapy (CBT) is the criterion standard treatment, but access is limited. OBJECTIVE: To test the hypothesis that internet-delivered CBT, which requires relatively little resources, is noninferior to face-to-face CBT in the treatment of health anxiety. DESIGN, SETTING, AND PARTICIPANTS: This randomized noninferiority clinical trial with health economic analysis was based at a primary care clinic and included patients with a principal diagnosis of health anxiety who were self-referred or referred from routine care. Recruitment began in December 10, 2014, and the last treatment ended on July 23, 2017. Follow-up data were collected up to 12 months after treatment. Analysis began October 2017 and ended March 2020. INTERVENTIONS: Patients were randomized (1:1) to 12 weeks of internet-delivered CBT or to individual face-to-face CBT. MAIN OUTCOMES AND MEASURES: Change in health anxiety symptoms from baseline to week 12. Analyses were conducted from intention-to-treat and per-protocol (completers only) perspectives, using the noninferiority margin of 2.25 points on the Health Anxiety Inventory, which has a theoretical range of 0 to 54. RESULTS: Overall, 204 patients (mean [SD] age, 39 [12] years; 143 women [70%]) contributed with 2386 data points on the Health Anxiety Inventory over the treatment period. Of 204 patients, 102 (50%) were randomized to internet-delivered CBT, and 102 (50%) were randomized to face-to-face CBT. The 1-sided 95% CI upper limits for the internet-delivered CBT vs face-to-face CBT difference in change were within the noninferiority margin in the intention-to-treat analysis (B = 0.00; upper limit: 1.98; Cohen d = 0.00; upper limit: 0.23) and per-protocol analysis (B = 0.01; upper limit: 2.17; Cohen d = 0.00; upper limit: 0.25). The between-group effect was not moderated by initial symptom level, recruitment path, or patient treatment preference. Therapists spent 10.0 minutes per patient per week in the online treatment vs 45.6 minutes for face-to-face CBT. The net societal cost was lower in the online treatment (treatment period point difference: $3854). There was no significant group difference in the number of adverse events, and no serious adverse event was reported. CONCLUSIONS AND RELEVANCE: In this trial, internet-delivered CBT appeared to be noninferior to face-to-face CBT for health anxiety, while incurring lower net societal costs. The online treatment format has potential to increase access to evidence-based treatment for health anxiety. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02314065.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Axelsson E, Andersson E, Ljótsson B, et al. Effect of Internet vs Face-to-Face Cognitive Behavior Therapy for Health Anxiety: A Randomized Noninferiority Clinical Trial. JAMA Psychiatry. 2020. PMID: 32401286. doi:10.1001/jamapsychiatry.2020.0940

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。